New insight into how Biogen's Tecfidera works may lead to better MS therapies

[cafead]

via Biogen’s top-selling Tecfidera (dimethyl fumarate) has proven to be an effective treatment for multiple sclerosis, bringing in $4.27 billion in sales in 2018, but its exact mechanism of action remains a mystery.

article source